Status:
UNKNOWN
The Development of a Screening Questionnaire to Discriminate Autism Spectrum Disorder and Schizotypal Disorder, and Validation of the Danish Version of RAADS-R
Lead Sponsor:
Glostrup University Hospital, Copenhagen
Conditions:
Autism Spectrum Disorder
Schizotypal Disorder
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The aim of the study is to investigate the validity, reliability and clinical features of a Danish version of the Ritvo Autism Asperger Diagnostic Scale-Revised (RAADS-R). A self-reporting scale devis...
Detailed Description
The study has 2 parts. Part 1: The objective is to develop and validate a self-report screening questionnaire to efficiently discriminate between Schizotypal Disorder (SD) and Autism Spectrum Disord...
Eligibility Criteria
Inclusion
- Al patient referred to the outpatient clinic for ADHD and Autism at PCG, in the research period, for diagnostic assessment of Autism Spectrum Disorder (Pervasive Developmental Disorder, infantile autism, atypical autism and Asperger Syndrome)
- WAIS \> 85, or Raven or no-clinical suspicion and education level of 11 years or above
- Completion of
- Clinical assessment
- Adult Asperger Assessment (AAA)
- Psychopathology evaluation using DSM-V
- A conclusion based on interdisciplinary consensus
Exclusion
- Insufficient Danish language skills
- Acute psychiatric illness prompting departure/dismissal from the diagnostic assessment
Key Trial Info
Start Date :
February 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 31 2023
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT05213286
Start Date
February 1 2022
End Date
August 31 2023
Last Update
March 16 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Glostrup University Hospital
Copenhagen, Denmark, 2605